logo

For the Inventor, By the Inventor

Rehovot, Israel

Esther Tzehoval

This inventor holds 5 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2011-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Esther Tzehoval. Retrieved from https://idiyas.com/inventor/esther-tzehoval

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 40.0

 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Nes Ziona, IL (2011 - 2013)
  • Rehovot, IL (2011 - 2022)

Company Filing History:

goldMedal5 out of 1,168 
 
Yeda Research and Develpment & Co. Ltd
 patents

Years Active: 2011-2022

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 11273178 - Affinity maturated T cell receptors and use thereof (2022-03-15),
2. 10081663 - Affinity maturated T cell receptors and use thereof (2018-09-25),
3. 8420078 - Methods and immunogenic cell preparations for treating antigen-associated diseases (2013-04-16),
4. 7960507 - Tumor associated antigen peptides and use of same as anti-tumor vaccines (2011-06-14),
5. 7906620 - Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines (2011-03-15),

Title: Esther Tzehoval: Innovator in T Cell Receptor Technology

Introduction

Esther Tzehoval is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of immunology, particularly in the development of T cell receptor (TCR) technologies. With a total of 5 patents to her name, Tzehoval is recognized for her innovative approaches to enhancing T cell responses.

Latest Patents

One of her latest patents is titled "Affinity maturated T cell receptors and use thereof." This invention relates to methods and systems for increasing the affinity of a T cell receptor to its ligand by subjecting the TCR gene to somatic hypermutation. The invention further explores the use of affinity maturated TCRs to create T cells that are reactive against selected antigens. This advancement holds promise for improving therapeutic strategies in cancer and autoimmune diseases.

Career Highlights

Esther Tzehoval has established herself as a key figure in her field through her work at Yeda Research and Development Co. Ltd. Her research focuses on the intersection of molecular biology and immunotherapy, contributing to the advancement of medical science.

Collaborations

Throughout her career, Tzehoval has collaborated with notable colleagues, including Lea Eisenbach and Boaz Tirosh. These partnerships have fostered a dynamic research environment, leading to innovative solutions in T cell technology.

Conclusion

Esther Tzehoval's contributions to T cell receptor technology exemplify her dedication to advancing immunological research. Her innovative patents and collaborative efforts continue to influence the field, paving the way for future breakthroughs in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…